Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality

Hassell KL(2010)Population estimates of sickle cell disease in the U.S Am J Prev Med 38 S512-S521

Charache S(1995)Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia N Engl J Med 332 1317-1322

Terrin ML(2014)Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members JAMA 312 1033-1048

Moore RD(2006)Sickle cell disease: a question of equity and quality Pediatrics 117 1763-1770

Dover GJ(2014)Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes Leuk Res 38 557-563

Barton FB(2009)Blood use in the ambulatory setting among elderly in the United States Transfusion 49 1186-1194

Eckert SV(2008)Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy Acta Haematol 120 195-198

Yawn BP(2014)Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care Pediatr Blood Cancer 61 697-701

Buchanan GR(2010)Evidence-based sickle cell pain management in the emergency department Adv Emer Nurs J 32 102-111

Afenyi-Annan AN(2010)Caring for the adult with sickle cell disease: results of a multidisciplinary pilot program J Natl Med Assoc 102 1009-1016

Hassell KL(2010)Population estimates of sickle cell disease in the U.S Am J Prev Med 38 S512-S521

Charache S(1995)Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia N Engl J Med 332 1317-1322

Terrin ML(2014)Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members JAMA 312 1033-1048

Moore RD(2006)Sickle cell disease: a question of equity and quality Pediatrics 117 1763-1770

Dover GJ(2014)Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes Leuk Res 38 557-563

Barton FB(2009)Blood use in the ambulatory setting among elderly in the United States Transfusion 49 1186-1194

Eckert SV(2008)Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy Acta Haematol 120 195-198

Yawn BP(2014)Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care Pediatr Blood Cancer 61 697-701

Buchanan GR(2010)Evidence-based sickle cell pain management in the emergency department Adv Emer Nurs J 32 102-111

Afenyi-Annan AN(2010)Caring for the adult with sickle cell disease: results of a multidisciplinary pilot program J Natl Med Assoc 102 1009-1016